Influence of Serotonin Transporter Gene Polymorphism (5-HTTLPR Polymorphism) on the Relation between Brain 5-HT Transporter Binding and Heart Rate Corrected Cardiac Repolarization Interval

• Esa Kauppila ,

  * E-mail: ekauppil@gmail.com

  Affiliations Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland, Department Clinical Physiology, North-Karelia Central Hospital, Joensuu, Finland

  ⨯
• Esko Vanninen,

  Affiliation Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland

  ⨯
• Salla Kaurijoki,

  Affiliation Department of Clinical Nutrition, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland

  ⨯
• Leila Karhunen,

  Affiliation Department of Clinical Nutrition, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland

  ⨯
• Kirsi H. Pietiläinen,

  Affiliations Obesity Research Unit, Department of Medicine, Division of Endocrinology, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland, Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland

  ⨯
• Aila Rissanen,

  Affiliation Obesity Research Unit, Department of Psychiatry, Helsinki University Hospital, Helsinki, Finland

  ⨯
• Jari Tiihonen,

  Affiliations Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden, Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland

  ⨯
• Ullamari Pesonen,

  Affiliation Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland

  ⨯
• Jaakko Kaprio

  Affiliations Department of Public Health, Hjelt Institute, University of Helsinki, Helsinki, Finland, Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland, Institute of Molecular Medicine, University of Helsinki, Helsinki, Finland

  ⨯